The risk for malignant primary adult-onset glioma in a large, multiethnic, managed-care cohort: Cigarette smoking and other lifestyle behaviors

Journal of Neuro-Oncology

Volumn 68, Issue 1, 2004, Pages 57-69

  Efird, Jimmy T ^a   Friedman, Gary D ^b,c   Sidney, Stephen ^c   Klatsky, Arthur ^c   Habel, Laurel A ^b,c   Udaltsova, Natalia V ^c   Van Den Eeden, Stephen ^b,c   Nelson, Lorene M ^b  

^a UNIVERSITY OF HAWAII   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DIVISION OF RESEARCH   (United States)

Author keywords

Alcohol; Cigarettes; Coffee; Gliomas; Marijuana

Indexed keywords

CANNABIS;

ADULT; ALCOHOL CONSUMPTION; ANAMNESIS; ARTICLE; CANCER RISK; CIGARETTE SMOKING; COFFEE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ETHNIC DIFFERENCE; FEMALE; FOLLOW UP; GLIOBLASTOMA; HEALTH PROGRAM; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; MEDICAL EXAMINATION; QUESTIONNAIRE; RACE DIFFERENCE; RISK ASSESSMENT; SEX DIFFERENCE; SMOKING HABIT; UNITED STATES; AGED; BEHAVIOR; BRAIN TUMOR; ETHNOLOGY; GLIOMA; MIDDLE AGED; ONSET AGE; RISK FACTOR; SMOKING;

ADULT; AGE OF ONSET; AGED; BEHAVIOR; BRAIN NEOPLASMS; CALIFORNIA; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GLIOMA; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; QUESTIONNAIRES; RISK FACTORS; SMOKING;

EID: 2942739008     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:NEON.0000024746.87666.ed     Document Type: Article

References (95)

1. Cancer Facts & Figures 2003/Cancer Prevention & Early Detection Facts & Figures 2003 (http://www.cancer.org). Atlanta. GA. 2003
2. Bondy M, Wrensch M: Epidemiology of primary malignant brain tumours. Baillieres Clin Neurol 5(2): 251-270, 1996
3. Choi N, Schuman L, Gullen W: Epidemiology of primary central nervous system neoplasms. II: case-control study. Am J Epidemiol 91: 467-485, 1970
4. Abramson Z, Kark J: Serum cholesterol and primary brain tumours: a case-control study. Br J Cancer 52: 93-98, 1985
5. Ahlbom A, Navier I, Norell S, Olin R, Spannare B: Non-occupational risk indicators for astrocytomas in adults. Am J Epidemiol 124: 334-337, 1986
6. Preston-Martin S, Mack W, Henderson B: Risk factors for gliomas and meningiomas in males in Los Angeles County. Cancer Res 49: 6137-6143, 1989
7. Mills P, Preston-Martin S, Annegers J, Becson L, Phillips R, Fraser G: Risk factors for tumors of the brain and cranial meninges in Seventh-Day Adventists. Neuroepidemiology 8: 266-275, 1989
8. Hochberg F, Toniolo P, Cole P: Nonocupational risk indicators of glioblastoma in adults. J Neuro-Oncol 8: 55-60, 1990
9. Brownson R, Reif J, Chang J, Davis J: An analysis of occupational risks for brain cancer. Am J Public Health 80: 169-172, 1990
10. Schlehofer B, Kunze S, Sachsenheimer W, Blettner M, Nichoff D, Wahrendorf J: Occupational risk factors for brain tumors: results from a population-based case-control study in Germany. Cancer Causes Control 1: 209-215, 1990
11. Blowers L, Preston-Martin S, Mack W: Dietary and other lifestyle factors of women with brain gliomas in Los Angeles County (California, USA). Cancer Causes Control 8: 5-12. 1997
12. Musicco M, Filippini G, Bordo B, Melotto A, Morello G, Berrino F: Gliomas and occupational exposure to carcinogens: case-control study. Am J Epidemiol 116: 782-790, 1982
13. Burch J, Craib K, Choi B, Miller A, Risch H, Howe G: An exploratory case-control study of brain tumors in adults. J Natl Cancer Inst 78: 601-609, 1987
14. Ryan P, Lee M, North B, McMichael A: Risk factors for tumors of the brain and meninges: results from the Adelaide adult brain tumor study. Int J Cancer 51: 20-27, 1992
15. Zampieri P, Meneghini F, Grigoletto F, Gerosa M, Licata C, Casentini L, Longatti P, Padoan A, Mingrino S: Risk factors for cerebral glioma in adults: a case-control study in an Italian population. J Neuro-Oncol 19: 61-67, 1994
16. Lee M, Wrensch M, Mike R: Dietary and tobacco risk factors for adult onset glioma in the San Francisco Bay Area (California, USA). Cancer Causes Control 8: 12-24, 1997
17. Preston-Martin S, Paganini-Hill A, Henderson B, Pike M, Wood C: Case-control study of intracranial meningiomas in women in Los Angeles County, California. J Natl Cancer Inst 65: 67-73, 1980
18. Hirayama T: Cancer mortality in nonsmoking women with smoking husbands based on a large-scale cohort study in Japan. Prev Med 13: 680-690, 1984
19. Zhang Z, Morgenstern H, Spitz M, Tashkin D, Yu G, Marshall J, Hsu T, Schantz S: Marijuana use and increased risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev 8: 1071-1078, 1999
20. Donald P: Marijuana smoking - possible cause of head and neck carcinoma in young patients. Otolaryngol Head Neck Surg 94: 517-520, 1986
21. Almadori G, Cerullo P, Ottaviani F, D'Alatri L: Marijuana smoking as a possible cause of tongue carcinoma in young patients. J Laryngol Otol 104: 896-899, 1990
22. Taylor F: Marijuana as a potential respiratory tract carcinogen: a retrospective analysis of a community hospital population. South Med J 81: 1213-1216, 1988
23. Sridhar K, Raub W, Weatherby N, Metsch L, Surratt H, Inciardi J, Duncan R, Anwyl R, McCoy C: Possible role of marijuana smoking as a carcinogen in the development 285-288, 1994
24. Sidney S, Quesenberry C, Friedman G, Tekawa I: Marijuana use ad cancer incidence (California, United States). Cancer Causes Control 8: 722-728, 1997
25. Robison L, Buckley J, Daigle A, Wells R, Benjamin D, Arthur D, Hammond G: Maternal drug use and risk of childhood nonlymphoblastic leukemia among offspring. Cancer 63: 1904-1911, 1989
26. Kuijten R, Bunin G, Nass C, Meadows A: Gestational and familial risk factors for childhood astrocytoma: results of a case-control study. Cancer Res 50: 2608-2612, 1990
27. Grufferman S, Schwartz A, Ruymann F, Maurer H: Parents use of cocaine will marijuana and increased risk of rhabdomyosarcoma in their children. Cancer Causes Control 4: 217-224, 1993
28. Bocing H, Schlehofer B, Blettner M, Wahrendorf J: Dietary carcinogens and the risk for glioma and meningioma in Germany. Int J Cancer 53: 561-565, 1993
29. Robinette C, Hrubee Z, Fraumeni J: Chronic alcoholism and subsequent mortality in world war II veterans. Am J Epidemiol 109: 687-700, 1979
30. Krieger N: Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Am J Public Health 82: 703-710, 1992
31. Hiatt R, Friedman G: The frequency of kidney and urinary tract diseases in a defined population. Kidney Int 22: 63-68, 1982
32. Karaffa M, ICD-9-CM: International classification of diseases, 9th revision, clinical modification. In: Karaffa MC (ed.) Practice Management Information Corporation, United States. 3rd edn., Vol 1-3. Health Care Financing Administration, Los Angeles, 1991
33. Friedman G: Effects of multiphasic health testing services (MHTS) on patients. In: Collen M (ed.) Multiphasic Health Testing Services. John Wiley & Sons, New York, 1978, pp 531-549
34. Percy C, Van Holten V, Muir C: International Classification of Diseases for Oncology = ICD-O. World Health Organization, Geneva, 1990
35. Friedman G, Habel L, Boles M, McFarland B: Kaiser Permanente Medical Care Program: Division of Research, Northern California, and Center for Health Research, Northwest Division. In: Strom B (ed.) Pharmacoepidemiology. 3rd edn., John Wiley & Sons, New York, 2000, pp 263-283
36. Crowder M, Kimber A, Smith R, Sweeting T: Statistical Analysis of Reliability Data. Chapman & Hall, London, 1991
37. Gurney J, Smith M, Bunin G: Chapter III: CNS and miscellaneous intracranial and intraspinal neoplasms. In: Ries L, Smith M, Gurney J, Linet M, Tamra T, Young J, Bunin G (eds) Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995. National Cancer Institute, SEER Program. NIH Pub. No. 99-4649. Bethesda, MD, 1999. pp 51-63
38. Brada M, Thomas G: Tumours of the brain and spinal cord in adults. In: Peckham M, Pinedo H, Veronesi U (eds) Oxford Textbook on Oncology. Oxford University Press, New York, 15.2, 1995. p 2063
39. International Agency for Research on Cancer (IARC): IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Vol 38. Tobacco Smoking. Lyon, 1986, pp 199-375
40. Johnson J, Houchens, Kluwe W, Craig D, Fisher G: Effects of mainstream and environmental tobacco smoke on the immune system in animals and humans: a review Crit Rev Toxicol 20: 369-395, 1990.
41. Winkelstein W: Smoking and cervical cancer - current status: a review. Am J Epidemiol 131: 945-957, 1990
42. Yamasaki E, Ames B: Concentration of mutagens from urine by adsorption with the nonpolar resin XAD-2: cigarette smokers have mutagenic urine. Proc Natl Acad Sci USA 74: 3555-3559, 1977
43. Petrakis N, Maack C, Lee R, Lyon M: Mutagenic activity in nipple aspirates of human breast fluid. Cancer Res 40: 188-189, 1980
44. Sasson I, Haley N, Hoffmann D, Wynder E, Hellberg D: Cigarette smoking and neoplasia of the uterine cervix: smoke constituents in cervical mucus. N Engl J Med 312: 315-316, 1985
45. Baron J, Rohan T: Tobacco. In: Schottenfeld D, Fraumeni J (eds) Cancer Epidemiol Biomarkers Prev. Oxford University Press. New York, 1996, pp 269-289
46. Hecht S, Hoffmann D: N-nitroso compounds and tobacco-induced cancers in man. In: O'Neill I, Chen J, Bartsch H (eds) Relevance to Human Cancer of N-nitroso Compounds. Tobacco Smoke and Mycotoxins. International Agency for Research on Cancer, Lyon. 1991. pp 54-61
47. Avtsyn A, Yablonovskaya L: Effects of disturbances in the hormonal status on experimental brain tumors. Acta Unio Int Contra Canerum 20: 1519-1522, 1964
48. Law M, Hackshaw A, Allaway S, Hale A: Cigarette smoking, sex hormones and bone density in women. Eur J Epidemiol 13: 553-558, 1997
49. Rich R, Fleisher T, Shearer W, Kotzin B, Schroeder H (eds) Clinical Immunology. 2nd edn., Mosby International Limited, London, 2001
50. Hochberg F, Miller D: Primary central nervous system lymphoma. J Neurosurg 68: 835-853, 1998
51. Sawamura Y, de Tribolet N: Immunobiology of brain tumors and implications for Immunotherapy. In: Kaye A, Lewis E (eds) Brain Tumors. Churchill Livingstone, Edinburgh. 1995, pp 113-124
52. George J, Levy Y, Shoenfeld Y: Smoking and immunity: an additional player in the mosaic of autoimmunity. Scand J Immunol 45: 1-6, 1997
53. Ahsan H, Neugut A, Gammon M: Association of adenocarcinoma and squamous cell carcinoma of the esophagus with tobacco-related and other malignancies. Cancer Epidemiol Biomarkers Prev 6: 779-782, 1997
54. Zang E, Wynder E: Differences in lung cancer risk between men and women: examination of the evidence. J. Natl Cancer Inst 88: 183-192, 1996
55. Muscat J, Richie J, Thompson S, Wynder E: Gender differences in smoking and risk for oral cancer. Cancer Res 56: 5192-5197, 1996
56. Begg C, Zhang Z, Sun M, Herr H, Schantz S: Methodology for evaluating incidence of second primary cancers with application to smoking-related cancers from the surveillance epidemiology and end results (SEER) program. Am J Epidemiol 142: 653-665, 1995
57. Kure E, Ryberg D, Hewer A, Phillips D, Skaug V, Baera R, Haugen A: p53 mutations in lung tumours: relationship to gender and lung DNA adducts. Carcinogenesis 17: 2201-2205, 1996
58. Nelson H, Christiani D, Mark E, Wiencke J, Wain J, Kelsey K: Implications and prognostic value of K-ras mutation for early-stage lung cancer in women. J Natl Cancer Inst 91: 2032-2038, 1999
59. Ryberg D, Hewer A, Phillips D: Different susceptibility to smoking-induced DNA damage among male and female lung cancer patients. Cancer Res 54: 5801-5803, 1991
60. Mollerup S, Ryberg D, Hewer A, Phillips D, Haugen A: Sex differences in lung CYP1A1 expression and DNA adduct levels among lung cancer patients. Cancer Res 59: 3317-3320, 1999
61. Guengerich F, Shimada T: Activation of procarcinogens by human cytochrome P450 enzymes. Mutat Res 400: 201-213, 1998
62. Wei Q, Cheng L, Amos C, Wang L, Guo Z, Hong W, Spitz M: Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study. J Natl Cancer Inst 92: 1764-1772, 2000
63. Gold E, Leviton A, Lopez R, Gilles F, Hedley-Whyte T, Kolonel L, Lyon J, Swanson G, Weiss N, West D, Aschenbrener C, Austin D: Parental smoking and risk of childhood brain tumors. Am J Epidemiol 137: 620-628, 1993
64. Filippini G, Maisonneuve P, McCredie M, Peris-Bonet R, Modan B, Preston-Martin S, Mueller B, Holly E, Cordier S, Choi N, Little J, Arslan A, Boyle P: Relationship of childhood brain tumors to exposure of parents and children to tobacco smoke: the SEARCH international case-control study. Int J Cancer 100: 206-213, 2002
65. Norman M, Holly E, Ahn D, Preston-Martin S, Mueller B, Bracci P: Prenatal exposure to tobacco smoke and childhood brain tumors: results from the United States west coast childhood brain tumor study. Cancer Epidemiol Biomarkers Prev 5: 127-133, 1996
66. Bunin G, Buckley J, Boesel C, Rorke L, Meadows A: Risk factors for astrocytic glioma and primitive neuroectodermal tumor of the brain in young children: a report from the children's cancer group. Cancer Epidemiol Biomarkers Prev 3: 197-204, 1994
67. Kuijten R, Bunin G, Nass C, Meadows A: Gestation and familial risk factors for children astrocytoma: results of a case-control study. Cancer Res 50: 2608-2612, 1990
68. Howe G, Burch J, Chiarelli A, Risch H, Choi B: An exploratory case-control study of brain tumors in children. Cancer Res 49: 4349-4352, 1989
69. Stjernfeldt M, Lindsten J, Berglund K, Ludvigsson J: Maternal smoking during pregnancy and risk of childhood cancer. Lancet 1: 1350-1352, 1986
70. McKinney P, Stiller C: Maternal smoking during pregnancy and the risk of childhood cancer. Lancet 2: 519-520, 1986
71. Cotdier S, Iglesias M, Goaster C, Guyot M, Mandereau L, Hemon D: Incidence and risk factors for childhood brain tumors in the Ile de France. Int J Cancer 59: 776-782, 1994
72. Gold E, Gordis L, Tonascia J, Szklo M: Risk factors for brain tumors in children. Am J Epidemiol 109: 309-319, 1979
73. Neutel C, Buck C: Effect of smoking during pregnancy on the risk of cancer in children. J Natl Cancer Inst 47: 59-63, 1971
74. Schuz J, Kaletsch U, Kaatsch P, Meinert R, Michaelis J: Risk factors for pediatric tumors of the central nervous system: results from a German population-based case-control study. Med Pediatr Oncol 36: 274-282, 2001
75. John E, Savitz D, Sandler D: Prenatal exposure to parents smoking and childhood cancer. Am J Epidemiol 133: 123-132, 1991
76. Filippini G, Farinotti M, Lovicu G, Masionneuve P, Boyle P: Mothers' active and passive smoking during pregnancy and the risk of brain tumours in children. Int J Cancer 57: 769-774, 1994
77. McCredie M, Maisonneuve P, Boyle P: Antenatal risk factors for malignant brain tumours in New South Wales children. Int J Cancer 56: 6-10, 1994
78. Preston-Martin S, Yu M, Benton B, Henderson B: N-nitroso compounds and children brain tumors: a case-control study. Cancer Res 42: 5240-5245, 1982
79. Sandler D, Everson R, Wilcox A, Browder J: Cancer risk in adulthood from early life exposure to parents' smoking. Am J Public Health 75: 487-492, 1985
80. Rogot E, Murray J: Smoking and causes of death umong US veterans: 16 years of observation. Public Health Rep 95: 213-222, 1980
81. Roth M, Marques-Magallanes J, Yuan M, Sun W, Tashkin D, Hankinson O: Induction and regulation of the carcinogen-metabolizing enzyme CYP1A1 by marijuana smoke and delta9-tetrahydrocannabinol. Am J Respir Cell Mol Biol 24: 339-344, 2001
82. Hecht S: N-nitrosamines. In: Enviromental and Occupational Medicine. 3rd edn., Lippincott-Raven Publishers, London. 1998. pp 1227-1238
83. Shapiro W, Shapiro J, Walker R: Central nervous system. In: Abeloff M, Armitage J, Lichter A, Niederhuber J (eds) Clinical Oncology. 2nd edn., Churchill Livington, New York. 2000
84. Roberts P: Neuroanatomy. 3rd edn., Springer-Verlag. New York, 1992
85. Tuomanen E: Breaching the blood-brain barrier. Sci Am 268: 80-84, 1993
86. Frey W: Bypassing the blood-brain barrier to deliver therapeutic agents to the brain and spinal cord. Drug Deliv Technol 2: 46-49, 2002
87. Liu X, Fawcett J, Thorne R, DeFor T, Frey W: Intranasal administration of insulin-like growth factor-1 bypasses the blood-brain barrier and protects against focal cerebral ischemic damage. J Neurol Sci 187: 91-97, 2001
88. Kuratsune M, Hueper W: Polycyclic aromatic hydrocarbons in coffee soots. J Natl Cancer Inst 20: 37-51, 1958
89. Challis B, Bartlen C: Possible cocarciogenic effects of coffee constituents. Nature 254: 532-533, 1975
90. Zimmerman H: Experimental brain tumors. In: Fields W, Sharkey P (eds) The Biology and Treatment of Intracranial Tumors. Charles C Thomas. Springfield. 1962. pp 49-74
91. Davidson B, Hsu T, Schantz S: The genetics of tobacco-induced malignancy. Arch Otolaryngol Head Neck Surg 119: 1198-1205, 1993
92. National Toxicology Program: NTP Carcinogenesis Studies of Trichloroethylene (Without Epichorohydrin) (CAS No. 79-01-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies). Natl Toxicol Program Tech Rep Ser 243: 1-174, 1990
93. Waters E, Gerstner H, Huff J: Tricholoroethylene. I. An overview. J Toxicol Environ Health 2: 671-707, 1977
94. Agency for Toxic Substances and Disease Registry (ATSDR): Toxicological profile for trichoroethylene. US Department of Health and Human Services. Public Health Service. Atlanta, GA, 1997
95. Peshin S, Lall S, Gupta S: Potential food contaminants and associated health risks. Acta Pharmacol Sin 23: 193-202, 2002